{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T00:00:59Z","timestamp":1782950459276,"version":"3.54.5"},"reference-count":30,"publisher":"BMJ","issue":"7","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Frontline Gastroenterol"],"accepted":{"date-parts":[[2020,8,15]]},"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>Eosinophilic oesophagitis (EoE) is a disease identified just over 30 years ago. The main symptom is dysphagia. EoE is initially inflammatory and progresses to fibrosis. There are differences in clinical presentation between young children and adults. Diagnosis is by endoscopy and six biopsies at varying positions of the oesophageal lining. Blood tests are of no diagnostic value as the condition is mediated by IgG<jats:sub>4<\/jats:sub> local mucosal pathology. Endoscopic signs are distinct from those of gastro-oesophageal reflux. Histological signs of EoE are &gt;15 eosinophils\/high-power field on a background of hyperplastic mucosa. Options of therapy include diet restriction, proton pump inhibitors therapy and topical steroids but there is a dearth of randomised control trials to define the optimum approach. The only licenced therapy for EoE is budesonide orodispersible tablet, a specific formulation for oesophageal topical steroid therapy. EoE is the most common cause of spontaneous perforation in the oesophagus. Stricture formation occurs in up to 10% and may require therapeutic dilatation.<\/jats:p>","DOI":"10.1136\/flgastro-2019-101313","type":"journal-article","created":{"date-parts":[[2020,9,7]],"date-time":"2020-09-07T17:26:16Z","timestamp":1599499576000},"page":"644-649","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":15,"title":["Eosinophilic oesophagitis: recent advances and practical management"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5761-157X","authenticated-orcid":false,"given":"Stephen","family":"Attwood","sequence":"first","affiliation":[{"name":"Health Services Research, Durham University, Durham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Epstein","sequence":"additional","affiliation":[{"name":"Paediatric Gastroenterology, Chelsea and Westminster Hospital NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2020,9,7]]},"reference":[{"key":"2025090709021868000_12.7.644.1","doi-asserted-by":"publisher","DOI":"10.1007\/BF01296781"},{"key":"2025090709021868000_12.7.644.2","unstructured":"CPT . International statistical classification of diseases and related health problems: ICD-10. Available: https:\/\/coder.aapc.com\/icd-10-codes\/K20.0#:~:text=ICD%2D10%20code%20K20.,Diseases%20of%20the%20digestive%20system%20 [Accessed 15 Jun 2020]."},{"key":"2025090709021868000_12.7.644.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.02.040"},{"key":"2025090709021868000_12.7.644.4","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e3181788282"},{"key":"2025090709021868000_12.7.644.5","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/apt.15231","article-title":"Systematic review with meta-analysis: the growing incidence and prevalence of eosinophilic oesophagitis in children and adults in population-based studies","volume":"49","author":"Navarro","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709021868000_12.7.644.6","doi-asserted-by":"publisher","DOI":"10.1136\/flgastro-2019-101176"},{"key":"2025090709021868000_12.7.644.7","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2013.10.027"},{"key":"2025090709021868000_12.7.644.8","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2011-301817"},{"key":"2025090709021868000_12.7.644.9","doi-asserted-by":"publisher","DOI":"10.1038\/ajg.2013.463"},{"key":"2025090709021868000_12.7.644.10","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1177\/2050640616689525","article-title":"Guidelines on eosinophilic esophagitis: evidence-based statements and recommendations for diagnosis and management in children and adults","volume":"5","author":"Lucendo","year":"2017","journal-title":"United European Gastroenterol J"},{"key":"2025090709021868000_12.7.644.11","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.05.036"},{"key":"2025090709021868000_12.7.644.12","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/apt.13676","article-title":"Allergy tests do not predict food triggers in adult patients with eosinophilic oesophagitis. A comprehensive prospective study using five modalities","volume":"44","author":"Philpott","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709021868000_12.7.644.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2012-303171"},{"key":"2025090709021868000_12.7.644.14","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2012.03.001"},{"key":"2025090709021868000_12.7.644.15","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2006.05.026"},{"key":"2025090709021868000_12.7.644.16","doi-asserted-by":"publisher","DOI":"10.1016\/0016-5085(95)90637-1"},{"key":"2025090709021868000_12.7.644.17","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2014.02.006"},{"key":"2025090709021868000_12.7.644.18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jaci.2017.08.038","article-title":"Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: the 2-4-6 study","volume":"141","author":"Molina-Infante","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"2025090709021868000_12.7.644.19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cgh.2015.07.041","article-title":"Efficacy of proton pump inhibitor drugs for inducing clinical and histologic remission in patients with symptomatic esophageal eosinophilia: a systematic review and meta-analysis","volume":"14","author":"Lucendo","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2025090709021868000_12.7.644.20","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/apt.13576","article-title":"A prospective open clinical trial of a proton pump inhibitor, elimination diet and\/or budesonide for eosinophilic oesophagitis","volume":"43","author":"Philpott","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"2025090709021868000_12.7.644.21","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1097\/MPG.0000000000002215","article-title":"Pediatric eosinophilic esophagitis: results of the European retrospective pediatric eosinophilic esophagitis registry (RetroPEER)","volume":"68","author":"Hoofien","year":"2019","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090709021868000_12.7.644.22","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1053\/j.gastro.2019.03.025","article-title":"Efficacy of budesonide orodispersible tablets as induction therapy for eosinophilic esophagitis in a randomized placebo-controlled trial","volume":"157","author":"Lucendo","year":"2019","journal-title":"Gastroenterology"},{"key":"2025090709021868000_12.7.644.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2014.05.021"},{"key":"2025090709021868000_12.7.644.24","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1038\/ajg.2016.238","article-title":"Swallowed fluticasone propionate is an effective long-term maintenance therapy for children with eosinophilic esophagitis","volume":"111","author":"Andreae","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"2025090709021868000_12.7.644.25","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/MPG.0000000000002672","article-title":"Differences in management of eosinophilic esophagitis in Europe: an assessment of current practice","volume":"71","author":"Tourlamain","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"2025090709021868000_12.7.644.26","doi-asserted-by":"publisher","DOI":"10.1016\/j.gie.2009.07.011"},{"key":"2025090709021868000_12.7.644.27","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2010.09.037"},{"key":"2025090709021868000_12.7.644.28","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2017-315414"},{"key":"2025090709021868000_12.7.644.29","doi-asserted-by":"publisher","DOI":"10.1097\/MPG.0b013e31829ce5ad"},{"key":"2025090709021868000_12.7.644.30","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.anai.2020.03.021","article-title":"Technical review on the management of eosinophilic esophagitis: a report from the AGA Institute and the joint Task force on allergy-immunology practice parameters","volume":"124","author":"Rank","year":"2020","journal-title":"Ann Allergy Asthma Immunol"}],"container-title":["Frontline Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/flgastro-2019-101313","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,7]],"date-time":"2025-09-07T16:02:25Z","timestamp":1757260945000},"score":1,"resource":{"primary":{"URL":"https:\/\/fg.bmj.com\/lookup\/doi\/10.1136\/flgastro-2019-101313"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,7]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2021,11,23]]},"published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1136\/flgastro-2019-101313"],"URL":"https:\/\/doi.org\/10.1136\/flgastro-2019-101313","relation":{},"ISSN":["2041-4137","2041-4145"],"issn-type":[{"value":"2041-4137","type":"print"},{"value":"2041-4145","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,7]]}}}